NCT06817889 2026-02-27
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Fred Hutchinson Cancer Center
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06597916 2024-11-27
RSV Vaccination in Immunocompromised Patients.
Medical University of Vienna
Phase 2 Recruiting
NCT06490549 2024-07-08
An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)
Institute of Hematology & Blood Diseases Hospital, China
Unknown
NCT01502072 2021-02-15
Respiratory Syncytial Virus - RSV Protocol
M.D. Anderson Cancer Center
Phase 2 Completed